Business Wire

DC-DALBERG-ADVISORS

25.3.2024 06:01:31 CET | Business Wire | Press release

Share
Dalberg Awarded 5-Year Contract to Strengthen United States Agency for International Development's (USAID) Work With the Private Sector

Dalberg Advisors (https://Dalberg.com/) has announced the award of the Private Sector Engagement Strategic Collaboration and Leading-Edge Engagement (“PSE SCALE”) program, a framework agreement of advisory services that will support the U.S. Agency for International Development (USAID: https://www.USAID.gov/) to engage the private sector to achieve development and humanitarian outcomes. Through the five-year, $99.1-million contract, Dalberg and its partners will support USAID to accelerate private sector partnerships around the world and transform the Agency’s capacity to work with the private sector.

PSE SCALE is an extension of over 20 years of efforts by USAID to increasingly partner and invest with the private sector to achieve the Agency’s development and humanitarian goals. It represents the flagship mechanism to upgrade USAID’s capacity to work with the private sector and will provide a range of technical and advisory services to USAID Missions and operating units seeking to expand or accelerate private sector engagement. Activities include support for strategy development, organizational effectiveness, workforce development, partnership facilitation, market research and more. In an increasingly complex global environment, the objective of this work is to position USAID as a capable and vital partner to companies seeking to drive growth and innovation in new markets, reduce risk, and advance sustainability goals.

Dalberg and a consortium of partners— 60 Decibels (https://60Decibels.com/), CrossBoundary (https://CrossBoundary.com/), Vera Solutions (https://VeraSolutions.org/), and Social Solutions International (https://www.SocialSolutions.biz/)—will provide a comprehensive and integrated suite of services that are delivered on-demand and in response to needs and opportunities in any operating unit across USAID. The team collectively brings decades of experience in serving clients globally across the public and private sectors on a wide range of sustainable development issues.

“Dalberg is thrilled to be supporting USAID in deepening its collaboration with the private sector. Our experience and local networks across markets in Africa, Asia, and Latin America makes Dalberg a natural partner for USAID,” said Gaurav Gupta, Dalberg’s Global Managing Partner. “And with over 1,100 clients across the public and private sectors, we have a long track record of designing successful cross-sector partnerships that help all parties to advance their goals.”

Distributed by APO Group on behalf of Dalberg Advisors.

Download image: https://apo-opa.co/4cw4lVk (Illustration of multi-sectorial activities)

About Dalberg Advisors:

Dalberg Advisors is a strategic advisory firm that combines private sector strategy skills and analytical capabilities with deep knowledge and networks across emerging and frontier markets. Dalberg works actively across the public, private, and philanthropic sectors to help clients achieve their goals and has over 500 employees across 25 locations in Africa, Asia-Pacific, Latin America, Europe, and the U.S. Dalberg Advisors is part of the Dalberg Group, which comprises a collection of mission-driven enterprises—Dalberg Advisors, Dalberg Data Insights, Dalberg Design, Dalberg Media, Dalberg Implement, Dalberg Research—and the not-for-profit, Dalberg Catalyst.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240324686686/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing5.2.2026 07:30:00 CET | Press release

Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ: Minato-ku, Tokyo; Chairman, President and Group CEO: Shigekazu Takeuchi) and Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano, “Sysmex”) have agreed on a sales collaboration for dementia testing. This agreement follows continued discussions based on the Basic Agreement on Business Collaboration in the Field of Immunoassay concluded in October 2023.1 Sysmex will exclusively sell Fujirebio's fully automated Lumipulse® immunoassay systems and dementia-related reagents ("the Products") in regions and countries mutually agreed upon by both companies. Going forward, Fujirebio and Sysmex will collaborate to meet the growing testing needs accompanying the wider adoption of therapeutic drugs and will gradually expand the countries where the Products are sold. Since entering into the Basic Agreement on Business Collaboration in Octob

Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide5.2.2026 06:30:00 CET | Press release

Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat®KMT2A + MRD Assay and Software to its industry-leading oncology portfolio. The assay leverages digital PCR (dPCR) to support both screening and precise longitudinal MRD monitoring for KMT2A rearrangements in acute myeloid leukemia (AML) subjects. This quantitative test is currently available for research use in clinical trials and as a stand-alone kit for purchase by our global customers, and will soon be available as a service in our regional LabPMM® laboratories worldwide. The assay is available to detect key AML-associated KMT2A rearrangements, which account for the vast majority of KMT2A fusion partners in AML1 and those most commonly targeted in menin-inhibitor clinical development programs. Later this year, the assay will be enhanced with four additional KMT2A rearrangements which are frequently found in acute lymphocytic leukemia (ALL), expan

VeriSilicon Enhanced ISP8200-FS Series IP Achieves ASIL B Functional Safety Certification5.2.2026 01:00:00 CET | Press release

Enabling Next-Generation High-Performance Automotive Camera Systems VeriSilicon (688521.SH) today announced its latest enhanced versions of Image Signal Processing (ISP) IP ISP8200-FS series, ISP8200-ES and ISP8200L-ES, featuring improved performance and energy efficiency to better support complex automotive camera systems. These enhanced IPs have successfully achieved ISO 26262 ASIL B functional safety certifications issued by TÜV NORD, an international inspection and certification institution, further validating their suitability and reliability for ADAS and autonomous driving applications. The latest enhanced ISP8200-FS series IP can operate at up to 1.2 GHz and support data processing from up to 16 image sensors. It significantly improves the performance of multi-camera scheduling, enabling flexible data-access capabilities and efficient hardware pipeline utilization for automotive camera systems. The enhanced series IP integrates image processing technologies including Color Noise

Kinaxis Inc. to Host Fourth Quarter 2025 Financial Results Conference Call on March 5, 20264.2.2026 22:30:00 CET | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in supply chain orchestration, today announced that it has scheduled its conference call to discuss the financial results for its fourth quarter and year ended December 31, 2025. The call will be hosted on Thursday, March 5 at 8:30 a.m. Eastern Time by Razat Gaurav, chief executive officer, and Blaine Fitzgerald, chief financial officer, followed by a question and answer period. The Company will report its financial results for the fourth quarter and year after the close of markets on Wednesday, March 4, 2026. CONFERENCE CALL DETAILS DATE: Thursday, March 5, 2026 TIME: 8:30 a.m. Eastern Time WEBCAST: https://events.q4inc.com/attendee/567578009 (available for three months) About Kinaxis Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that

Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota4.2.2026 22:30:00 CET | Press release

Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. “We are pleased that another Blue Cross Blue Shield payer has joined Anthem in making ReActiv8 available to well-selected patients after reviewing the large body of clinical evidence we have built,”said Jason Hannon, CEO of Mainstay Medical. “Patients with intractable chronic low back pain are desperately seeking durable solutions, and ReActiv8 has proven to be a safe and effective solution through six clinical studies with 633 patients treated and 1,950 patient-years of follow-up, including two multi-center, randomized controlled clinical studies. We look forward to

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye